High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies

J.J. Fütterer, S. Verma, T. Hambrock, D. Yakar and J.O. Barentsz

Abdominal Imaging 2012;37:892-896

DOI PMID

Abstract

Transrectal ultrasound-guided biopsy is the gold standard for prostate cancer detection. The latter detection rates of random systematic TRUS-guided biopsy do not exceed 44 As a consequence other biopsy methods have been explored. One of these methods is MR-guided biopsy (MRGB), which revealed detection rates of 38-59% after previous negative TRUSGB sessions. For this reason MRGB will probably become more and more applied in daily practice.

A pdf file of this publication is available for personal use. Enter your e-mail address in the box below and press the button. You will receive an e-mail message with a link to the pdf file.